SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist

Detalles Bibliográficos
Autores principales: Bozonnat, Alizée, Assan, Florence, LeGoff, Jérôme, Bourrat, Emmanuelle, Bachelez, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235915/
https://www.ncbi.nlm.nih.gov/pubmed/34176064
http://dx.doi.org/10.1007/s10875-021-01076-6
_version_ 1783714428596781056
author Bozonnat, Alizée
Assan, Florence
LeGoff, Jérôme
Bourrat, Emmanuelle
Bachelez, Hervé
author_facet Bozonnat, Alizée
Assan, Florence
LeGoff, Jérôme
Bourrat, Emmanuelle
Bachelez, Hervé
author_sort Bozonnat, Alizée
collection PubMed
description
format Online
Article
Text
id pubmed-8235915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82359152021-06-28 SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist Bozonnat, Alizée Assan, Florence LeGoff, Jérôme Bourrat, Emmanuelle Bachelez, Hervé J Clin Immunol Letter to Editor Springer US 2021-06-26 2021 /pmc/articles/PMC8235915/ /pubmed/34176064 http://dx.doi.org/10.1007/s10875-021-01076-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to Editor
Bozonnat, Alizée
Assan, Florence
LeGoff, Jérôme
Bourrat, Emmanuelle
Bachelez, Hervé
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title_full SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title_fullStr SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title_full_unstemmed SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title_short SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
title_sort sars-cov-2 infection inducing severe flare up of deficiency of interleukin thirty-six (il-36) receptor antagonist (ditra) resulting from a mutation invalidating the activating cleavage site of the il-36 receptor antagonist
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235915/
https://www.ncbi.nlm.nih.gov/pubmed/34176064
http://dx.doi.org/10.1007/s10875-021-01076-6
work_keys_str_mv AT bozonnatalizee sarscov2infectioninducingsevereflareupofdeficiencyofinterleukinthirtysixil36receptorantagonistditraresultingfromamutationinvalidatingtheactivatingcleavagesiteoftheil36receptorantagonist
AT assanflorence sarscov2infectioninducingsevereflareupofdeficiencyofinterleukinthirtysixil36receptorantagonistditraresultingfromamutationinvalidatingtheactivatingcleavagesiteoftheil36receptorantagonist
AT legoffjerome sarscov2infectioninducingsevereflareupofdeficiencyofinterleukinthirtysixil36receptorantagonistditraresultingfromamutationinvalidatingtheactivatingcleavagesiteoftheil36receptorantagonist
AT bourratemmanuelle sarscov2infectioninducingsevereflareupofdeficiencyofinterleukinthirtysixil36receptorantagonistditraresultingfromamutationinvalidatingtheactivatingcleavagesiteoftheil36receptorantagonist
AT bachelezherve sarscov2infectioninducingsevereflareupofdeficiencyofinterleukinthirtysixil36receptorantagonistditraresultingfromamutationinvalidatingtheactivatingcleavagesiteoftheil36receptorantagonist

Ejemplares similares